Open an account

Arcadia Biosciences

RKDA · NASDAQ

$0.153+$0.008 (+5.52%)TodayMarket closed ·
Prev close $0.145

About RKDA

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. The company is headquartered in Dallas, Texas and currently employs 8 full-time employees. The company went IPO on 2015-05-15. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. The company has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

Employees
8
Headquarters
Dallas, Texas
Listed
May 15, 2015
Sector
Consumer Staples
Industry
Food Products
Website
arcadiabio.com

RKDA key statistics

Market cap
368.61K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.96M
Volume
257.93K
Open price
$0.14
High today
$0.155
Low today
$0.137
52 Week high
$5.23
52 Week low
$0.111

Arcadia Biosciences (RKDA) at a glance

As of Oct 20, 2026, Arcadia Biosciences (RKDA) shares are priced at $0.153, giving the company a market cap of 368.61K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.137 and $0.155. The current price is 11.7% above the day's low and 1.3% below its high.

Volume so far is 257.93K shares, below the average of 4.96M shares a day.

Over the past year Arcadia Biosciences has ranged from $0.111 to $5.23, and now sits 1% of the way up that range.

Arcadia Biosciences met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q3 FY25 it reported $0.62 per share against an estimate of -$0.5508.

RKDA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 126.2% on average.

  1. Q4 FY23: reported -$2.52 per share against an estimate of -$2.64
  2. Q1 FY24: reported -$1.78 per share against an estimate of -$2.26
  3. Q2 FY24: reported $0.78 per share against an estimate of $1.58
  4. Q3 FY24: reported -$1.18 per share against an estimate of -$0.8262
  5. Q4 FY24: reported -$2.99 per share against an estimate of -$0.9078
  6. Q1 FY25: reported $1.90 per share against an estimate of -$0.9996
  7. Q2 FY25: reported $0.02 per share against an estimate of -$0.8058
  8. Q3 FY25: reported $0.62 per share against an estimate of -$0.5508

RKDA news

  • 12 Consumer Staples Stocks Moving In Monday's After-Market Session

  • 12 Consumer Staples Stocks Moving In Thursday's After-Market Session

  • 12 Consumer Staples Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

  • 12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

  • Erica Kollmann

    Soybean Short Squeeze: Cooking Oil Stocks Pop After Trump Targets China

  • Vishaal Sanjay

    Trump's Cooking Oil Comment Wipes Out $450 Billion In Minutes: 'Beijing Will See This As Weakness,' Says China Expert

  • Mohd Haider

    Australian Oilseeds Holdings Shares Soar 248% After Hours Amid Trump Says US Will Make Its Own Cooking Oil

Similar companies

Companies in the same industry as Arcadia Biosciences

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.